RELIV INTERNATIONAL INC
Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | |
|---|---|---|---|---|---|---|
| Revenue | $35.1M | $36.1M | $41.8M | $45.5M | $51.8M | $57.3M |
| Operating income | −$559,458 | −$1.9M | −$183,403 | −$811,979 | −$1.3M | $95,730 |
| Net income | −$444,357 | −$1.9M | −$696,912 | −$625,055 | −$1.2M | $724,569 |
| Total assets | $15.3M | $16.4M | $21.1M | $22.5M | $24.3M | $26.8M |
| Total liabilities | — | — | — | — | — | — |
| Equity | $11.1M | $12.0M | $14.4M | $14.9M | $15.9M | $17.0M |
| EPS (diluted) | $-0.25 | $-1.03 | $-0.38 | $-0.34 | $-0.67 | $0.06 |
| Shares out. | 1.7M | 1.8M | 1.8M | 12.9M | 12.8M | 12.7M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2019- Operating margin
- −1.6%
- Net margin
- −1.3%
- Return on equity
- −4.0%
- Return on assets
- −2.9%
- Return on capital (ROCE)
- −4.9%
- Liabilities / assets
- —
- Debt / equity
- —
- Book value / share
- $6.36
- Revenue growth (YoY)
- −2.9%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2019- Accruals / assets
- 3.3%clean
- Piotroski F-Score
- 4/8mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 4 warning● 1 good- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- Negative operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Material events
SEC Form 8-K · most recent- Delisting / listing-standard noticeDec 23, 2020
- Delisting / listing-standard noticeDec 7, 2020
- Results of operationsNov 13, 2020
- New financial obligationNov 9, 2020
- Delisting / listing-standard noticeOct 19, 2020
- Results of operationsAug 14, 2020
- Results of operationsMay 15, 2020
- New financial obligationMay 6, 2020
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SC 13G/AFeb 11, 2021
- 15-12GFORM 15-12GJan 19, 2021
- SC 13E3/ASCHEDULE 13E3/AJan 19, 2021
- 8-KFORM 8-KDec 23, 2020
- 25FORM 25Dec 21, 2020
- 8-KFORM 8-KDec 7, 2020
- SC 13E3/ASCHEDULE 13E3/ANov 24, 2020
- DEF 14CFORM DEF 14CNov 24, 2020
- PRER14CFORM PRER14CNov 20, 2020
- PRER14CFORM PRER14CNov 18, 2020
- SC 13E3/ASCHEDULE 13E3/ANov 18, 2020
- CORRESPNov 17, 2020
- 10-QFORM 10-QNov 13, 2020
- 8-KFORM 8-KNov 13, 2020
- 8-KFORM 8-KNov 9, 2020
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.